Condition
Arthritis, Septic
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05531227UnknownPrimary
Corticosteroid Therapy for Persistent Synovitis in Acute Septic Arthritis on Native Joint
NCT04460144Completed
Rapid Diagnostic Test for Septic Arthritis
NCT03615781Not ApplicableCompletedPrimary
Two Versus Four Weeks of Antibiotic Treatment in Native Joint Arthritis
Showing all 3 trials